|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||38.72 - 38.72|
|52-week range||26.55 - 66.96|
|Beta (5Y monthly)||0.88|
|PE ratio (TTM)||15.61|
|Forward dividend & yield||1.18 (3.05%)|
|Ex-dividend date||17 May 2023|
|1y target est||N/A|
Fresenius Medical Care AG & Co. KGaA ( ETR:FME ) came out with its full-year results last week, and we wanted to see...
Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.